MILLENNIUM MANAGEMENT LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1273087
NEW YORK, NY
Position in LCTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,954,322
-$4,832,648 QoQ
Shares Held
3,018,567
-45.7% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 130 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. LCTX ranks #185 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in LCTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,954,322 | 3,018,567 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,786,970 | 5,561,374 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,524,399 | 2,110,419 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,529,205 | 2,680,003 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,366,525 | 2,600,577 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $168,978 | 168,978 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $61,713 | 41,698 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $63,217 | 57,998 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $2,103,184 | 1,402,123 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $466,875 | 399,039 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $572,133 | 506,313 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,612,304 | 1,020,446 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $274,879 | 178,493 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $816,389 | 333,220 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $48,951 | 19,425 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $3,350,573 | 1,425,776 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $624,365 | 354,753 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $336,076 | 357,528 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,354 | 14,200 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||